HR6572-119

In Committee

Launching X–Labs for Breakthrough Science Act

119th Congress Introduced Dec 10, 2025

Summary

What This Bill Does

The Launching X-Labs for Breakthrough Science Act creates a new NIH X-Labs Initiative in Public Health Service Act title IV. NIH would provide long-term institutional awards to eligible entities to conduct breakthrough biomedical research and acquire research and development plant. The Director must create an XL-series activity code available across NIH institutes and centers. Award categories include XL01 for basic science research institutions needing stable long-term funding, XL02 for science institutions developing datasets, measurement tools, or techniques with defined deliverables, XL03 for nonprofit institutions that fund focused research organizations, individual researchers, research collaborations, or centers, and XL04 for forming and planning new scientific institutions that may later qualify for other categories. The bill defines eligible entities, breakthrough biomedical research, basic science research institution, focused research organization, R&D plant, and oversight terms, and requires award conditions, reporting, and oversight through NIH mechanisms.

Who Benefits and How

Basic science research institutions benefit from stable long-term XL01 support with less budgetary reprogramming pressure. Science institutions benefit from XL02 awards for datasets, measurement tools, and techniques. Nonprofit funders of focused research organizations benefit from XL03 awards. New scientific ventures benefit from XL04 formation and planning support. Biomedical researchers benefit from institutional funding aimed at high-risk breakthrough work. Patients benefit indirectly if breakthrough research leads to better understanding, tools, or treatments.

Who Bears the Burden and How

NIH program officials must create the X-Labs Initiative, manage XL-series activity codes, compete and oversee awards, review eligible entities, and enforce reporting requirements. NIH institutes and centers must administer award categories and oversight. Federal taxpayers bear multi-year institutional award costs. Award recipients must comply with eligibility, reporting, deliverable, and oversight conditions. New institutions must plan around federal requirements before becoming eligible for larger awards.

Key Provisions

  • Establishes the NIH X-Labs Initiative for long-term institutional awards.
  • Creates XL01, XL02, XL03, and XL04 award categories for basic science, scientific resources, focused research, and new institutions.
  • Directs NIH to designate an XL-series activity code available across institutes and centers.
  • Supports acquisition of R&D plant needed for breakthrough biomedical research.
  • Requires NIH oversight, eligibility rules, award conditions, and reporting.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Creates an NIH X-Labs Initiative providing long-term institutional awards for breakthrough biomedical research, scientific resources, focused-research organizations, and new scientific institutions, with XL-series activity codes, eligibility rules, oversight, and reporting.

Key Policy Areas

Biomedical Research, NIH, Grants

Primary Purpose

Creates an NIH X-Labs Initiative providing long-term institutional awards for breakthrough biomedical research, scientific resources, focused-research organizations, and new scientific institutions, with XL-series activity codes, eligibility rules, oversight, and reporting.

Policy Domains

Biomedical Research NIH Grants

Substantive provisions

Identified Gains
  • Basic science research institutions
  • Science institutions developing datasets
  • Focused research organizations
  • New scientific ventures
  • Biomedical researchers
  • Patients
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Patients: ,
Biomedical researchers: ,
New scientific ventures: ,
Focused research organizations: ,
Basic science research institutions: ,
Science institutions developing datasets: ,
Identified Costs
  • NIH program officials
  • NIH institutes
  • Federal taxpayers
  • Award recipients
  • New scientific institutions
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
NIH institutes: ,
Award recipients: ,
Federal taxpayers: ,
NIH program officials: ,
New scientific institutions: ,

Legislative Progress

In Committee
Introduced Committee Passed
Dec 10, 2025

Referred to the House Committee on Energy and Commerce.

Dec 10, 2025

Introduced in House

Dec 10, 2025

Mr. Harder of California (for himself and Mr. Obernolte) introduced …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Research & Science
10 mentions across 2 clauses
+8 positive -2 negative

Award recipients, Basic science research institutions, Focused research organizations

Positive-direction: Basic science research institutions, Focused research organizations, New scientific ventures, Science institutions developing datasets

Negative-direction: Award recipients

Government
2 mentions across 2 clauses
-2 negative

NIH program officials

Taxpayers
2 mentions across 2 clauses
-2 negative

Taxpayers

2/3
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Biomedical Research NIH Grants
Actor Mappings
"agencies"
→ ['NIH']
"programs"
→ ['X-Labs Initiative']

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology